ERD

17 items found

Toggle all information

Global blood miRNA profiling unravels early miRNA signatures of the immunogenicity of licensed Ebola vaccine rVSVΔG-ZEB...

Project: VSV-EBOPLUS

Updated at: 29-04-2024

Show more information

Project acronym VSV-EBOPLUS

Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across...

Project: VSV-EBOPLUS

Updated at: 29-04-2024

Show more information

Project acronym VSV-EBOPLUS

Distribution of serum, plasma and RNA samples in pediatric trial in Lambaréné

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Correlates of vaccine-induced protective immunity against Ebola virus disease

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola viru...

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Methods for predicting vaccine immunogenicity and reactogenicity

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Distribution of samples (serum, plasma, Paxgene tubes) to partners involved in immunogenicity / transcriptomic studies

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus va...

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Safety, immunogenicity and risk–benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I–III clinical t...

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Distribution of month 48 samples from phase I/II clinical trials in Switzerland and Gabon

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Distribution of month 60 samples from phase I/II clinical trials in Switzerland and Gabon

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Distribution of month 24 samples from phase I/II clinical trials in Switzerland and Gabon

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and No...

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Distribution of month 36 samples from phase I/II clinical trials in Switzerland and Gabon

Project: VSV-EBOPLUS

Updated at: 30-10-2023

Show more information

Project acronym VSV-EBOPLUS

Periodic Reporting for period 4 - VSV-EBOPLUS (SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOVEBOLA V...

Project: VSV-EBOPLUS

Updated at: 01-03-2023

Show more information

Project acronym VSV-EBOPLUS